Adagrasib
![KRASG12C Inhibitors for NSCLC: How Garsorasib Stands Out](https://pharmtales.com/wp-content/uploads/2023/07/Results-from-Garsorasib-Expand-the-Class-of-KRASG12C-Inhibitors-in-NSCLC.jpg)
Results from Garsorasib Expand the Class of KRASG12C Inhibitors in NSCLC
SG Tylor
Early findings from the use of garsorasib (D-1553), an oral KRASG12C inhibitor, in patients with advanced nonโsmall cell lung cancer ...
Early findings from the use of garsorasib (D-1553), an oral KRASG12C inhibitor, in patients with advanced nonโsmall cell lung cancer ...